Skip to main content
SpringerLink
Log in

Management of the Neck in Cancer of the Salivary Glands

  • Chapter
Salivary Gland Disorders

  • 3497 Accesses

Abstract

  • Discussion of risk factors for metastasis from cancer of the salivary glands

  • Algorithm for management of the clinically negative (N0) neck in cancer of the salivary glands based upon clinical assessment, fine-needle aspiration biopsy, and frozen section pathology

  • Management of the clinically positive (N+) neck, including neck dissection and postoperative radiation therapy

  • Future directions in understanding salivary gland tumorigenesis and cervical metastasis, such as using molecular markers for prognosis and developing targeted therapy

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Affolter A, Helmbrecht S, Finger S, Hormann K, Gotte K (2005) Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses. Oncol Rep 13(6):1089–194

    PubMed  CAS  Google Scholar 

  2. Agulnik M and Siu LL (2004) An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents. Curr Med Chem Anticancer Agents 4(6):543–551

    Article  PubMed  CAS  Google Scholar 

  3. Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, and Spiro RH (1992) The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 69(3):615–619

    Article  PubMed  CAS  Google Scholar 

  4. Bardwil J (1967) Tumors of the parotid gland. Am J Surg 114:498–502

    Article  Google Scholar 

  5. Batsakis JG (1986) Carcinomas of the submandibular and sublingual glands. Ann Otol Rhinol Laryngol 95(2 Pt 1):211–212

    PubMed  CAS  Google Scholar 

  6. Bhattacharyya N and Fried MP (2002) Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg 128(8):904–908

    PubMed  Google Scholar 

  7. Bilal H, Handra-Luca A, Bertrand JC, and Fouret PJ (2003) P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem 51(2):133–139

    PubMed  CAS  Google Scholar 

  8. Bosch A, Brandenburg JH, and Gilchrist KW (1980) Lymph node metastases in adenoid cystic carcinoma of the submaxillary gland. Cancer 45(11):2872–2877

    Article  PubMed  CAS  Google Scholar 

  9. Bui CD, Ching AS, Carlos RC, Shreve PD, and Mukherji SK (2003) Diagnostic accuracy of 2-[fluorine-18]fluro-2-deoxy-D-glucose positron emission tomography imaging in nonsquamous tumors of the head and neck. Invest Radiol 38(9):593–601

    Article  PubMed  CAS  Google Scholar 

  10. Califano L, Zupi A, Massari PS, and Giardino C (1993) Indication for neck dissection in carcinoma of the parotid gland. Our experience on 39 cases. Int Surg 78(4):347–349

    PubMed  CAS  Google Scholar 

  11. Chou C, Zhu G, Luo M, and Xue G (1996) Carcinoma of the minor salivary glands: results of surgery and combined therapy. J Oral Maxillofac Surg 54(4):448–453

    Article  PubMed  CAS  Google Scholar 

  12. Darling MR, Schneider JW, and Phillips VM (2002) Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol 38(7):641–645

    Article  PubMed  Google Scholar 

  13. Emanuel P, Wang B, Wu M, and Burstein DE (2005) p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol 18(5):645–650

    Article  PubMed  Google Scholar 

  14. Etges A, Pinto DS, Jr., Kowalski LP, Soares FA, Araujo VC (2003) Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour. J Clin Pathol 56(12):914–918

    Article  PubMed  CAS  Google Scholar 

  15. Fan CY, Melhem MF, Hosal AS, Grandis JR, and Barnes EL (2001) Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma. Arch Otolaryngol Head Neck Surg 127(9):1075–1079

    PubMed  CAS  Google Scholar 

  16. Ferlito A, Pellitteri PK, Robbins KT, Shaha AR, Kowalski LP, Silver CE, Anniko M, Rinaldo A, Medina JE, Bradley PJ, and Byers RM (2002) Management of the neck in cancer of the major salivary glands, thyroid and parathyroid glands. Acta Otolaryngol 122(6):673–678

    Article  PubMed  Google Scholar 

  17. Ferlito A, Shaha AR, Rinaldo A, and Mondin V (2001) Management of clinically negative cervical lymph nodes in patients with malignant neoplasms of the parotid gland. ORL J Otorhinolaryngol Relat Spec 63(3):123–126

    PubMed  CAS  Google Scholar 

  18. Foschini MP, Gaiba A, Cocchi R, Pennesi MG, and Pession A (2005) p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Int J Surg Pathol 13(4):329–335

    Article  PubMed  CAS  Google Scholar 

  19. Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, and Goepfert H (1993) Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg 119(5):517–520

    PubMed  CAS  Google Scholar 

  20. Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, and Peters LJ (1997) Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 37(1):79–85

    Article  PubMed  CAS  Google Scholar 

  21. Garden AS, Weber RS, Ang KK, Morrison WH, Matre J, and Peters LJ (1994) Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure. Cancer 73(10):2563–2569

    Article  PubMed  CAS  Google Scholar 

  22. Johns ME (1980) Parotid cancer: a rational basis for treatment. Head Neck Surg 3(2):132–141

    Article  PubMed  CAS  Google Scholar 

  23. Kawahara A, Harada H, Yokoyama T, and Kage M (2005) p63 Expression of clear myoepithelial cells in epithelialmyoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology. Cancer 105(4):240–245

    Article  PubMed  CAS  Google Scholar 

  24. Kelley DJ and Spiro RH (1996) Management of the neck in parotid carcinoma. Am J Surg 172(6):695–697

    Article  PubMed  CAS  Google Scholar 

  25. Keyes JW Jr., Harkness BA, Greven KM, Williams DW, 3rd, Watson NE Jr., and McGuirt WF (1994) Salivary gland tumors: pretherapy evaluation with PET. Radiology 192(1):99–102

    PubMed  Google Scholar 

  26. Kishi M, Nakamura M, Nishimine M, Ikuta M, Kirita T, and Konishi N (2005) Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 41(2):161–169

    Article  PubMed  CAS  Google Scholar 

  27. Korkmaz H, Yoo GH, Du W, Hocwald E, Otero-Garcia JE, Volkan Adsay N, Shibuya T, and Jacobs JR (2002) Predictors of nodal metastasis in salivary gland cancer. J Surg Oncol 80(4):186–189

    Article  PubMed  Google Scholar 

  28. Krause CJ (1981) The management of parotid neoplasms. Head Neck Surg 3(4):340–343

    Article  PubMed  CAS  Google Scholar 

  29. Laskawi R, Rodel R, Zirk A, and Arglebe C (1998) Retrospective analysis of 35 patients with acinic cell carcinoma of the parotid gland. J Oral Maxillofac Surg 56(4):440–443

    Article  PubMed  CAS  Google Scholar 

  30. Layfield LJ and Gopez EV (2002) Cystic lesions of the salivary glands: cytologic features in fine-needle aspiration biopsies. Diagn Cytopathol 27(4):197–204

    Article  PubMed  Google Scholar 

  31. Licitra L, Grandi C, Prott FJ, Schornagel JH, Bruzzi P, and Molinari R (2003) Major and minor salivary glands tumours. Crit Rev Oncol Hematol 45(2):215–225

    Article  PubMed  Google Scholar 

  32. Lim JJ, Kang S, Lee MR, Pai HK, Yoon HJ, Lee JI, Hong SP, and Lim CY (2003) Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. J Oral Pathol Med 32(9):552–651

    Article  PubMed  Google Scholar 

  33. Lopes MA, Santos GC, and Kowalski LP (1998) Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 20(8):699–706

    Article  PubMed  CAS  Google Scholar 

  34. Ma DQ and Yu GY (1987) Tumours of the minor salivary glands. A clinicopathologic study of 243 cases. Acta Otolaryngol 112:106–109

    Google Scholar 

  35. Maruya S, Kies MS, Williams M, Myers JN, Weber RS, Batsakis JG, and El-Naggar AK (2005) Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications. Hum Pathol 36(7):821–827

    Article  PubMed  CAS  Google Scholar 

  36. McGuirt WF (1989) Management of occult metastatic disease from salivary gland neoplasms. Arch Otolaryngol Head Neck Surg 115(3):322–325

    PubMed  CAS  Google Scholar 

  37. Nagler RM, Kerner H, Ben-Eliezer S, Minkov I, and Ben-Itzhak O (2003) Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies. Oncology 64(4):389–398

    Article  PubMed  CAS  Google Scholar 

  38. Nasser SM, Faquin WC, and Dayal Y (2003) Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 119(6):801–806

    Article  PubMed  CAS  Google Scholar 

  39. Otsuka H, Graham MM, Kogame M, and Nishitani H (2005) The impact of FDG-PET in the management of patients with salivary gland malignancy. Ann Nucl Med 19(8):691–694

    Article  PubMed  Google Scholar 

  40. Pedersen D, Overgaard J, Sogaard H, Elbrond O, and Overgaard M (1992) Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 102(9):1064–1069

    Article  PubMed  CAS  Google Scholar 

  41. Pohar S, Gay H, Rosenbaum P, Klish D, Bogart J, Sagerman R, Hsu J, and Kellman R (2005) Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes. Int J Radiat Oncol Biol Phys 61(1):112–118

    Article  PubMed  Google Scholar 

  42. Potencz E, Cornianu M, Muntean C, and Sotiriadis S (1998) The expression of p53 protein in salivary gland carcinomas. Rom J Morphol Embryol 44(1–4):109–115

    PubMed  CAS  Google Scholar 

  43. Poulsen MG, Tripcony LB, and Kynaston B (1991) Nodal recurrence in primary malignant epithelial tumours of the parotid gland. Australas Radiol 35(2):169–173

    PubMed  CAS  Google Scholar 

  44. Regis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V, Flavia Logullo A, and Magrin J (2001) Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 127(1):56–60

    PubMed  CAS  Google Scholar 

  45. Seethala RR, LiVolsi VA, and Baloch ZW (2005) Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of lesions of the parotid gland. Head Neck 27(3):217–223

    Article  PubMed  Google Scholar 

  46. Seethala RR, LiVolsi VA, Zhang PJ, Pasha TL, Baloch ZW (2005) Comparison of p63 and p73 expression in benign and malignant salivary gland lesions. Head Neck 27(8):696–702

    Article  PubMed  Google Scholar 

  47. Shah JP (1990) Cervical lymph node metastases-diagnostic, therapeutic, and prognostic implications. Oncology (Williston Park) 4(10):61–9; discussion 72, 76

    PubMed  CAS  Google Scholar 

  48. Spiro RH (1986) Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8(3):177–184

    Article  PubMed  CAS  Google Scholar 

  49. Spiro RH (1995) Changing trends in the management of salivary tumors. Semin Surg Oncol 11(3):240–245

    Article  PubMed  CAS  Google Scholar 

  50. Spiro RH, Huvos AG, Berk R, and Strong EW (1978) Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg 136(4):461–8

    Article  PubMed  CAS  Google Scholar 

  51. Spiro RH, Huvos AG, and Strong EW (1974) Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg 128(4):512–520

    Article  PubMed  CAS  Google Scholar 

  52. Spiro RH, Huvos AG, and Strong EW (1975) Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. Am J Surg 130(4):452–459

    Article  PubMed  CAS  Google Scholar 

  53. Stanley MW (2002) Selected problems in fine needle aspiration of head and neck masses. Mod Pathol 15(3):342–350

    Article  PubMed  Google Scholar 

  54. Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schroder U, Eckel HE, and Klussmann JP (2003) High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 129(7):720–723

    Article  PubMed  Google Scholar 

  55. Stewart CJ, MacKenzie K, McGarry GW, and Mowat A (2000) Fine-needle aspiration cytology of salivary gland: a review of 341 cases. Diagn Cytopathol 22(3):139–146

    Article  PubMed  CAS  Google Scholar 

  56. Storey MR, Garden AS, Morrison WH, Eicher SA, Schechter NR, and Ang KK (2001) Postoperative radiotherapy for malignant tumors of the submandibular gland. Int J Radiat Oncol Biol Phys 51(4):952–958

    Article  PubMed  CAS  Google Scholar 

  57. Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, Ebihara S, and Takeyama I (1992) Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope 102(8):923–927

    Article  PubMed  CAS  Google Scholar 

  58. Sung MW, Kim KH, Kim JW, Min YG, Seong WJ, Roh JL, Lee SJ, Kwon TK, and Park SW (2003) Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129(11):1193–1197

    Article  PubMed  Google Scholar 

  59. Terhaard CH, Lubsen H, Rasch CR, Levendag PC, Kaanders HH, Tjho-Heslinga RE, van Den Ende PL, and Burlage F (2005) The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61(1):103–111

    Article  PubMed  Google Scholar 

  60. Theriault C and Fitzpatrick PJ (1986) Malignant parotid tumors. Prognostic factors and optimum treatment. Am J Clin Oncol 9(6):510–516

    Article  PubMed  CAS  Google Scholar 

  61. Uchida Y, Minoshima S, Kawata T, Motoori K, Nakano K, Kazama T, Uno T, Okamoto Y, and Ito H (2005) Diagnostic value of FDG PET and salivary gland scintigraphy for parotid tumors. Clin Nucl Med 30(3):170–176

    Article  PubMed  Google Scholar 

  62. Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, and Hart AA (1999) Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors. Cancer 85(10):2255–2264

    Article  Google Scholar 

  63. Zbaren P, Nuyens M, Loosli H, and Stauffer E (2004) Diagnostic accuracy of fine-needle aspiration cytology and frozen section in primary parotid carcinoma. Cancer 100(9):1876–1883

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, University of Pittsburgh, School of Medicine, 200 Lothrop Street The Eye & Ear Institute, Suite 500, Pittsburgh, PA, 15213, USA

    Kristin B. Gendron MD (Visiting Instructor)

  2. Department of Otolaryngology and of Immunology, University of Pittsburgh, School of Medicine, Pittsburgh

    Robert L. Ferris MD, PhD, FACS (Associate Professor and Chief, Co-Leader)

  3. Cancer Immunology Program, University of Pittsburgh Cancer Institute, 200 Lothrop Street, Suite 500, Pittsburgh, PA, 15213, USA

    Robert L. Ferris MD, PhD, FACS (Associate Professor and Chief, Co-Leader)

Authors
  1. Kristin B. Gendron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert L. Ferris MD, PhD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Otolaryngology, University of Pittsburgh, School of Medicine The Eye & Ear Institute, Suite 519, 200 Lothrop Street, Pittsburgh, PA, 15213, USA

    Eugene N. Myers MD, FACS, FRCS Edin (Hon) (Distinguished Professor and Emeritus Chair) (Distinguished Professor and Emeritus Chair)

  2. Department of Otolaryngology and of Immunology, University of Pittsburgh, School of Medicine, Pittsburgh

    Robert L. Ferris MD, PhD, FACS (Associate Professor, Chief and Co-Leader) (Associate Professor, Chief and Co-Leader)

  3. Cancer Immunology Program, University of Pittsburgh Cancer Institute, 200 Lothrop Street, Suite 500, Pittsburgh, PA, 15213, USA

    Robert L. Ferris MD, PhD, FACS (Associate Professor, Chief and Co-Leader) (Associate Professor, Chief and Co-Leader)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Gendron, K.B., Ferris, R.L. (2007). Management of the Neck in Cancer of the Salivary Glands. In: Myers, E.N., Ferris, R.L. (eds) Salivary Gland Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-47072-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-47072-4_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-47070-0

  • Online ISBN: 978-3-540-47072-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation